InhibrxInc Free Cash Flow vs Market Capitalization Analysis
| INBX Stock | USD 34.61 0.13 0.37% |
InhibrxInc financial indicator trend analysis is infinitely more than just investigating InhibrxInc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InhibrxInc is a good investment. Please check the relationship between InhibrxInc Free Cash Flow and its Market Cap accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.
Free Cash Flow vs Market Cap
Free Cash Flow vs Market Capitalization Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InhibrxInc Free Cash Flow account and Market Capitalization. At this time, the significance of the direction appears to have very strong relationship.
The correlation between InhibrxInc's Free Cash Flow and Market Capitalization is 0.83. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Market Capitalization in the same time period over historical financial statements of InhibrxInc, assuming nothing else is changed. The correlation between historical values of InhibrxInc's Free Cash Flow and Market Capitalization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of InhibrxInc are associated (or correlated) with its Market Capitalization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Market Capitalization has no effect on the direction of Free Cash Flow i.e., InhibrxInc's Free Cash Flow and Market Capitalization go up and down completely randomly.
Correlation Coefficient | 0.83 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Market Cap
Most indicators from InhibrxInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InhibrxInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.At this time, InhibrxInc's Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 210 M in 2024, whereas Tax Provision is likely to drop 2,565 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 83.7M | 131.3M | 219.8M | 230.8M | Cost Of Revenue | 2.7M | 2.8M | 1.2M | 1.1M |
InhibrxInc fundamental ratios Correlations
Click cells to compare fundamentals
InhibrxInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
InhibrxInc fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Current Liab | 4.8M | 13.4M | 9.6M | 17.2M | 43.3M | 45.5M | |
| Total Current Liabilities | 20.6M | 31.4M | 22.5M | 27.6M | 56.3M | 59.1M | |
| Other Liab | 363K | 2.9M | 917K | 110K | 126.5K | 120.2K | |
| Net Tangible Assets | (93.6M) | 75.5M | 52.4M | 58.1M | 66.8M | 70.1M | |
| Retained Earnings | (69.3M) | (145.4M) | (227.1M) | (372.4M) | (613.7M) | (583.0M) | |
| Accounts Payable | 3.1M | 13.5M | 9.1M | 8.3M | 11.0M | 7.2M | |
| Other Current Assets | 376K | 132.2M | 7.8M | 6.6M | 16.7M | 22.7M | |
| Total Current Assets | 15.6M | 132.2M | 139.1M | 280.5M | 295.4M | 310.1M | |
| Property Plant Equipment | 10.7M | 11.3M | 9.5M | 2.5M | 2.9M | 2.7M | |
| Total Assets | 26.5M | 143.7M | 150.5M | 290.9M | 307.9M | 323.3M | |
| Short Long Term Debt Total | 41.7M | 37.5M | 70.5M | 202.1M | 210.1M | 220.6M | |
| Total Stockholder Equity | (93.6M) | 75.5M | 52.4M | 58.1M | 43.5M | 45.7M | |
| Property Plant And Equipment Net | 10.7M | 11.3M | 9.5M | 7.2M | 9.4M | 8.2M | |
| Current Deferred Revenue | 7.9M | 3.1M | 2.0M | 166K | 149.4K | 141.9K | |
| Net Debt | 30.2M | (91.2M) | (60.8M) | (71.8M) | (67.8M) | (64.4M) | |
| Cash | 11.5M | 128.7M | 131.3M | 273.9M | 277.9M | 291.8M | |
| Non Current Assets Total | 10.9M | 11.6M | 11.3M | 10.4M | 12.5M | 9.9M | |
| Long Term Debt | 30.4M | 29.2M | 70.5M | 202.1M | 207.0M | 217.3M | |
| Cash And Short Term Investments | 11.5M | 128.7M | 131.3M | 273.9M | 277.9M | 291.8M | |
| Net Receivables | 438K | 615K | 878K | 257K | 778K | 497.4K | |
| Common Stock Shares Outstanding | 36.6M | 25.3M | 38.0M | 40.1M | 47.1M | 38.2M | |
| Liabilities And Stockholders Equity | 26.5M | 143.7M | 150.5M | 290.9M | 307.9M | 323.3M | |
| Non Current Liabilities Total | 99.5M | 36.9M | 75.6M | 205.2M | 208.1M | 111.2M | |
| Capital Lease Obligations | 7.8M | 8.2M | 6.7M | 5.0M | 3.2M | 4.9M | |
| Inventory | 3.2M | (129.3M) | (878K) | (257K) | (231.3K) | (242.9K) | |
| Other Stockholder Equity | (24.3M) | 220.8M | 279.5M | 430.4M | 657.2M | 690.1M | |
| Total Liab | 120.1M | 68.3M | 98.1M | 232.8M | 264.4M | 140.0M | |
| Net Invested Capital | (59.6M) | 104.7M | 70.5M | 260.1M | 250.5M | 263.0M | |
| Property Plant And Equipment Gross | 10.7M | 11.3M | 3.2M | 2.5M | 16.1M | 16.9M | |
| Accumulated Other Comprehensive Income | (1.7M) | (59.5M) | (143.7M) | (150.5M) | (135.4M) | (128.6M) | |
| Net Working Capital | (5.0M) | 100.8M | 116.7M | 252.9M | 239.0M | 251.0M | |
| Short Term Debt | 4.7M | 1.5M | 1.7M | 1.9M | 2.1M | 2.6M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.